Abstract:Background EGFR mutations and EML4-ALK rearrangements are key therapeutic targets in nonsquamous non-small-cell lung carcinoma (nsNSCLC). Current guidelines recommend testing all patients with advanced nsNSCLC (stages IIIB and IV). Objective To evaluate physician attitudes about molecular testing for nsNSCLC and to determine the rate of testing, the effect of biopsy sample size, and prevalence of driver mutations . Materials and methods In this retrospective study, 206 cases of advanced nsNSCLC were identified… Show more
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.